Volume 28 in the series of Side Effects of Drugs Annuals (http://www.elsevier.com/locate/series/seda) continues to serve its primary goal: to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has reviewed new data and trends by selecting from the year's writing all that is truly new and informative, by critically interpreting it, and by pointing to whatever is unproven or misleading. The use of the book is enhanced by separate indexes, allowing the reader to access the text via drug name, adverse effect, or drug interaction. The current annual includes an essay by the editor, Dr Jeffrey Aronson, entitled 'Classifying Drug Adverse Reactions in the 21st Century.' In it he describes how the modern approach to classifying adverse drug reactions takes into account the dose that causes the reaction, the time-course of the reaction, and the susceptibility factors that increase the individual patient's risk, and shows how this analysis can facilitate regulatory decision making.
Les mer
Provides clinicians and medical investigators with a yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. This title includes an essay that describes the modern approach to classifying adverse drug reactions.
Les mer
Classifying adverse drug reactions in the 21st century J.K. Aronson 1. Central nervous system stimulants and drugs that suppress appetite R.P. Sequeira 2. Antidepressant drugs P.J. Cowen 3. Lithium D.L. Dunner 4. Drugs of abuse J.K. Patel, Timothy E Ralston, and E.J. wong 5. Hypnotics and sedatives S. Curran and S. Musa 6. Antipsychotic drugs A. Carvajal,L.H. Martin Arias and Natalia Jimeno 7. Antiepileptic drugs A. Gil-Nagel 8. Opioid analgesics and narcotic antagonists A.H. Ghodse and A.M. Baldacchino 9. Anti-inflammatory and antipyretic analgesics and drugs used in gout A. Del Favero 10. General anesthetics and therapeutic gases Y. Young 11. Local anesthetics S.A. Schug, P. Flisberg, S.A. Jackson, D.J. O'Connnor 12. Neuromuscular blocking agents and skeletal muscle relaxants O. Zuzan and M. Leuwer 13. Drugs that affect autonomic functions or the extrapyramidal system M. Schachter 14. Dermatological drugs and topical agents S.R. Knowles, G. Wong, N.H. Shear 15. Antihistamines (H1 receptor antagonists) G.M. Walsh 16. Drugs acting on the respiratory tract M. Joerger, K. Hartmann, and M. Kuhn 17. Positive inotropic drugs and drugs used in dysrhythmias J.K. Aronson 18. Beta-adrenoceptor antagonists and antianginal drugs A.P. Maggioni, M.G. Franzosi, and R. Latini 19. Drugs acting on the cerebral and peripheral circulations R. Verhaeghe 20. Antihypertensive drugs P. Joubert 21. Diuretics D.A. Sica 22. Metals G.B. van der Voet and F.A. de Wolff 23. Metal antagonists R.H.B. Meyboom 24. Antiseptic drugs and disinfectants P. Magee 25. Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines T. Midtvedt 26. Miscellaneous antibacterial drugs A. Imhof 27. Antifungal drugs A.H. Groll, H. Kolve, and T.J. Walsh 28. Antiprotozoal drugs J. Buser, K. Fattinger 29. Antiviral drugs P.L. Vernazza, P. Schmid 30. Drugs used in tuberculosis and leprosy S. Swaminathan 31. Antihelminthic drugs P.J.J. van Genderen 32. Vaccines S. Dittmann 33. Blood, blood components, plasma and plasma products P.J.M. Vossebeld, P. Stangers and W.G. van Aken 34. Formulations used in nutrition M.C. Allwood and G. Hardy 35. Drugs affecting blood coagulation, fibrinolysis, and hemostasis D. Keeling and J.K. Aronson 36. Gastrointestinal drugs S. Dar, H.N. Dalton 37. Drugs that act on the immune system: cytokines and monoclonal antibodies T.Vial, J. Descotes, C. Ludwig, and M. Behrend 38. Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs F. Braun and M. Behrend 39. Corticotrophins, corticosteroids, and prostaglandins J. Costa and M. Farre 40. Sex hormones and related compounds, including hormonal contraceptives M.N.G. Dukes 41. Thyroid hormones iodine, and antithyroid drugs. J.A. Franklyn 42. Insulin, glucagon, and hypoglycemic drugs H.M.J. Krans 43. Miscellaneous hormones R. Page 44. Drugs that affect lipid metabolism I. Aursnes 45. Cytostatic drugs Hans-Peter Lipp, Joerg Thomas Hartmann, and Andrew Stanley 46. Radiological contrast agents S.K. Morcos 47. Drugs used in ocular treatment B.C.P. Polak 48. Treatments used in complementary and alternative medicine E. Ernst 49. Miscellaneous drugs and materials, medical devices and techniques N.H. Choulis and J.K. Aronson
Les mer

Produktdetaljer

ISBN
9780444515711
Publisert
2005-11-29
Utgiver
Vendor
Elsevier Science Ltd
Vekt
1380 gr
Høyde
240 mm
Bredde
165 mm
Aldersnivå
06, P
Språk
Product language
Engelsk
Format
Product format
Heftet
Antall sider
694

Biographical note

Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK's National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.